Common Stock, Shares, Outstanding of Cartesian Therapeutics, Inc. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cartesian Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Cartesian Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 26,011,106, a 0.95% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Cartesian Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 26,011,106 +243,737 +0.95% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 26,003,606 +2,107,081 +8.8% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 26,000,065 +8,183,827 +46% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 25,936,101 +20,420,265 +370% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 25,767,369 +20,369,772 +377% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 23,896,525 -130,957,507 -85% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 17,816,238 -135,611,333 -88% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 5,515,836 -147,911,147 -96% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 5,397,597 -147,644,838 -96% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 154,854,032 +1,825,210 +1.2% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 153,427,571 +714,360 +0.47% 30 Jun 2023 10-Q 17 Aug 2023 2023 Q2
Q1 2023 153,426,983 +29,046,139 +23% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 153,042,435 +29,419,470 +24% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 153,028,822 +37,585,322 +33% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 152,713,211 +37,633,919 +33% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 124,380,844 +11,403,840 +10% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 123,622,965 +15,551,716 +14% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 115,443,500 +8,207,524 +7.7% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 115,079,292 +14,231,482 +14% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 112,977,004 +25,957,832 +30% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 108,071,249 +21,745,702 +25% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 107,235,976 +59,039,589 +122% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 100,847,810 +55,894,859 +124% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 87,019,172 +42,231,147 +94% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 86,325,547 +63,853,771 +284% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 48,196,387 +25,800,204 +115% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 44,952,951 +22,556,768 +101% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 44,788,025 +22,438,185 +100% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 22,471,776 +128,522 +0.58% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 22,396,183 +275,676 +1.2% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 22,396,183 +340,036 +1.5% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 22,349,840 +3,797,455 +20% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 22,343,254 +3,904,512 +21% 31 Dec 2017 10-K 15 Mar 2019 2018 Q4
Q3 2017 22,120,507 +3,932,194 +22% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 22,056,147 +4,160,323 +23% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 18,552,385 31 Mar 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 18,438,742 +16,265,343 +748% 31 Dec 2016 10-K 15 Mar 2018 2017 Q4
Q3 2016 18,188,313 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 17,895,824 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q4 2015 2,173,399 31 Dec 2015 10-K 28 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.